D. Torres

Saint Louis Hospital Interventional Radiology

Author of 1 Presentation

2206.6 - Outcome of prostatic artery embolization for benign prostatic hyperplasia: 1550 patients follow up to 10 years



To evaluate the outcome of prostatic artery embolization (PAE) for symptomatic benign prostatic hyperplasia (BPH) patients with moderate to severe lower urinary tract symptoms (LUTS).

Material and methods

Between March 2009 and February 2019, 1550 patients with symptomatic BPH and severe LUTS underwent PAE.The prostate was larger than 100 cm³ in 312 patients and 156 patients were in acute urinary retention (AUR).


There was a statistically significant (P< 0.001) change from baseline to observed value in the evaluated parameters. The cumulative clinical success rates at short, medium and long term follow up were 88.1% (95% CI, 77.6% - 92.4%), 85.1% (95% CI, 71.3% - 93.1%), and 76.8% (95% CI, 69.1 – 84.6%), respectively. From the 156 patients in AUR, 140 (89.7%) had the bladder catheter removed between 2 days and 3 months; 10 had repeated successful PAE and 6 had surgery. From the 312 patients with prostate larger than 100 were there was clinical success in 252 (80.7%) (95% CI 78.2% - 93.1%) at short term, in 242- 77.6% (95% CI, 74.8% - 84.9%) at medium and in 235 (75.3%) (95% CI, 72.4% - 82%) at long term. There were 3 major complications, a bladder wall ischemia, a perineal pain for 3 months without sequela and a patient had expelled prostate fragments and AUR treated by TURP without sequela.


Due to the good clinical results of PAE for symptomatic BPH patients with moderate to severe LUTS at short, mid and long term follow up, PAE may become the standard procedure for BPH.